EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases

Xinqi Li iD, Rongli Li iD, Jialing Huang iD, Yuelin Hu iD, Chenxi Fan iD, Xin Wang iD, Hongsong Yu iD

Stem Cells International · 2025-01 · 2025 (1)

DOI: 10.1155/sci/9440377 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells International, online erschienen am 15.04.2025. Verfasst von Xinqi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases (AIDs) occur when the immune system mistakenly attacks the body’s own antigens. Traditionally, these conditions are treated with nonspecific immunosuppressive therapies, including corticosteroids, immunosuppressants, biological agents, and human immunoglobulins. However, these treatments often fail to achieve optimal outcomes, especially for patients with severe cases. Mesenchymal stem cells (MSCs) present a promising alternative due to their robust self‐renewal capabilities and multidirectional differentiation potential. MSCs are easily accessible, exhibit low immunogenicity, and can help reduce graft rejection. MSCs can inhibit T cell proliferation, reduce proinflammatory T cells, inhibit B cell differentiation, induce macrophage polarization towards the anti‐inflammatory M2 phenotype, and suppress activity of natural killer (NK) cells and dendritic cells (DCs). Additionally, MSCs can regulate T cells, macrophages, and fibroblast‐like synoviocytes (FLS) by releasing microRNA (miRNA) through exosomes or extracellular vesicles (EVs), thus providing therapeutic benefits for various diseases. Numerous clinical trials have highlighted the therapeutic benefits of MSCs in treating various AIDs, leading to increased interest in MSC transplantation. This review summarizes the current applications and mechanisms of action of MSCs in the treatment of AIDs.

Schlagwörter

Stichwörter der Autor:innen

applicationsautoimmune diseaseclinical trialsmechanismsmesenchymal stem cells

Autor:innen und Institutionen

  • Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi, China.
  • School of Basic Medical Sciences, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, China.

ORCID-Profile: Xinqi Li, Rongli Li, Jialing Huang, Yuelin Hu, Chenxi Fan, Xin Wang, Hongsong Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Li, R., Huang, J., Hu, Y., Fan, C., Wang, X., & Yu, H. (2025). Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases. Stem Cells International, 2025(1). https://doi.org/10.1155/sci/9440377

Vancouver

Li X, Li R, Huang J, Hu Y, Fan C, Wang X, et al. Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases. Stem Cells International. 2025;2025(1). doi:10.1155/sci/9440377

BibTeX
@article{Li2025,
  author = {Li, Xinqi and Li, Rongli and Huang, Jialing and Hu, Yuelin and Fan, Chenxi and Wang, Xin and Yu, Hongsong},
  title = {Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases},
  journal = {Stem Cells International},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/sci/9440377}
}
Kostenlos starten →